Live feed
Filing
SC 13D/A
SC 13D/A0001193125-18-305844·Eiger BioPharmaceuticals, Inc.
Schedule 13D ownership disclosure
EIGER BIOPHARMACEUTICALS INC
Security class unavailable · CUSIP: 28249U105
Event date: 2018-10-18
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 9.5000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-18-305844
- Form type
- SC 13D/A
- Filer
- Eiger BioPharmaceuticals, Inc.
- CIK
- CIK 1305253
- Filed
- Oct 24, 2018
- Reporting period
- Oct 18, 2018
- Description
- Schedule 13D beneficial ownership